Listen to the article
Pennsylvania insurance giant Aetna has agreed to pay $118 million to settle allegations that it systematically misclassified obesity diagnoses in Medicare Advantage plans, according to court documents filed this week in the Eastern District of Pennsylvania.
The settlement resolves a whistleblower lawsuit filed under the False Claims Act by former Aetna executive Camillo Gallucci in 2019. Gallucci, who served as the insurer’s medical director for the mid-Atlantic region, claimed Aetna fraudulently inflated government reimbursements through improper coding practices related to obesity diagnoses.
Federal prosecutors, who joined the case in 2023, alleged that Aetna knowingly misrepresented patient conditions to increase its risk adjustment payments from Medicare. The scheme centered on the company’s practice of classifying patients with a body mass index (BMI) of 30 or higher as having “morbid obesity,” a more serious condition that commands higher reimbursement rates from the federal government.
“Accurate coding is essential to the integrity of the Medicare Advantage program,” said U.S. Attorney Jacqueline C. Romero in a statement. “When insurers manipulate diagnosis codes solely to increase their profits, they undermine the system and divert taxpayer dollars from their intended purpose.”
The Justice Department’s investigation revealed the practice occurred between 2015 and 2018, affecting thousands of Medicare beneficiaries across Pennsylvania and potentially other states. The government contends that Aetna’s actions violated both the False Claims Act and the Financial Institutions Reform, Recovery, and Enforcement Act.
Under the Medicare Advantage program, private insurers like Aetna receive higher payments for covering patients with more severe health conditions based on a risk adjustment factor. By incorrectly coding patients with regular obesity as having morbid obesity, Aetna allegedly received millions in improper reimbursements.
Healthcare fraud experts note this case highlights ongoing concerns about risk adjustment practices in the rapidly growing Medicare Advantage market, which now covers more than 30 million Americans—roughly half of all Medicare beneficiaries.
“This settlement reflects the government’s continued focus on risk adjustment fraud in Medicare Advantage plans,” said Jennifer Weaver, a healthcare compliance attorney not involved in the case. “With enrollment growing and federal spending increasing, we’re seeing heightened scrutiny of how insurers code patient conditions.”
As the whistleblower who initiated the case, Gallucci stands to receive approximately $21 million from the settlement under the qui tam provisions of the False Claims Act, which allow whistleblowers to receive a percentage of recovered funds.
Aetna, a subsidiary of CVS Health since 2018, did not admit wrongdoing as part of the settlement. In a statement, the company said it agreed to the resolution “to avoid the uncertainty and expense of protracted litigation” while emphasizing its commitment to regulatory compliance.
“We maintain robust compliance programs and are committed to adhering to all regulations governing our business,” the company stated. “This settlement allows us to move forward and continue focusing on our mission of improving health outcomes for our members.”
The case comes amid broader industry scrutiny. In recent years, the Justice Department has recovered billions from healthcare companies for similar alleged coding violations. Just last year, Humana paid $197 million to settle allegations that it submitted inaccurate diagnosis codes, while UnitedHealth Group faced a $573 million settlement in 2022.
Pennsylvania Insurance Commissioner Michael Humphreys indicated the settlement funds will primarily return to the federal Medicare program, with a portion allocated to cover investigation costs and compensate the whistleblower.
The settlement also requires Aetna to implement enhanced compliance measures, including additional auditing protocols and staff training on proper diagnostic coding practices. The company must also submit to monitoring by an independent review organization for three years.
Industry analysts suggest the settlement could prompt other insurers to review their own coding practices, potentially affecting how companies manage their Medicare Advantage plans nationwide.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
21 Comments
This settlement highlights the importance of accurate coding and reporting in government healthcare programs. Insurers must be held to the highest standards of transparency and integrity.
Absolutely. Deceptive coding practices that inflate reimbursements are a form of fraud that cannot be tolerated, as they divert resources away from patient care.
While the $118 million settlement is a significant amount, I hope this case leads to broader reforms to improve coding transparency and accountability in the Medicare Advantage program.
This case highlights the need for robust monitoring and enforcement to ensure Medicare Advantage plans are not exploiting loopholes or misrepresenting patient data. Maintaining program integrity should be a top priority.
Manipulating diagnosis codes to increase Medicare Advantage payments is concerning. I’m glad the government is cracking down on this type of fraud to protect taxpayer funds.
Absolutely, this settlement sends a strong message that such practices will not be tolerated. Insurers must be held accountable for accurate and ethical coding.
The alleged misclassification of obesity diagnoses to boost reimbursements is a concerning example of how insurers may try to exploit vulnerabilities in government healthcare programs. Improved transparency and accountability measures are clearly needed.
While $118 million is a hefty penalty, it’s important that large insurers face consequences for defrauding government healthcare programs. Hopefully this leads to more transparency and integrity in coding practices.
Yes, significant fines are necessary to deter this type of systematic misconduct. Oversight and auditing of coding practices are crucial to prevent future abuse.
Misrepresenting patient conditions to boost Medicare Advantage payments is unethical and undermines the entire program. I’m glad to see the government taking this issue seriously.
This is a significant settlement over alleged Medicare Advantage coding fraud. It’s important that insurers accurately report patient conditions to avoid inflating government reimbursements.
Agreed, proper coding is crucial for the integrity of government healthcare programs. Misclassification of patient diagnoses to boost payments is unacceptable.
It’s good to see the government taking action against fraudulent coding practices that inflate Medicare reimbursements. Insurers must be held accountable for accurately representing patient conditions.
Agreed. Proper coding and reporting is essential to the proper functioning of government healthcare programs like Medicare Advantage.
While the $118 million penalty is substantial, it’s critical that large insurers face meaningful consequences for exploiting government healthcare programs through improper coding. Integrity and accountability must be prioritized.
This settlement underscores the importance of accurate coding and reporting in the Medicare Advantage program. Insurers must be held to the highest standards of integrity to protect the system’s long-term viability.
Absolutely. Deceptive coding practices that inflate reimbursements undermine the entire purpose of government healthcare programs and must be addressed through robust enforcement.
This case serves as a wake-up call for the need to strengthen oversight and auditing of coding practices in the Medicare Advantage program. Insurers must be held accountable for accurately representing patient conditions.
Agreed. Proactive monitoring and enforcement are essential to prevent future attempts at gaming the system and defrauding government healthcare programs.
This case is a concerning example of how some insurers may try to game the system and inflate their reimbursements. Improved oversight and auditing are clearly needed to protect the integrity of Medicare Advantage.
Yes, it’s crucial that the government continues to closely monitor coding practices and take enforcement action against any attempts at fraud or abuse.